- Home
- ETON vs UONEK Comparison
ETON vs UONEK Comparison
Compare ETON & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- UONEK
- Stock Information
- Founded
- ETON 2017
- UONEK 1980
- Country
- ETON United States
- UONEK United States
- Employees
- ETON N/A
- UONEK N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- UONEK Broadcasting
- Sector
- ETON Health Care
- UONEK Consumer Discretionary
- Exchange
- ETON Nasdaq
- UONEK Nasdaq
- Market Cap
- ETON 388.3M
- UONEK 31.6M
- IPO Year
- ETON 2018
- UONEK N/A
- Fundamental
- Price
- ETON $14.85
- UONEK $0.81
- Analyst Decision
- ETON Strong Buy
- UONEK
- Analyst Count
- ETON 3
- UONEK 0
- Target Price
- ETON $29.67
- UONEK N/A
- AVG Volume (30 Days)
- ETON 636.4K
- UONEK 240.0K
- Earning Date
- ETON 08-07-2025
- UONEK 08-07-2025
- Dividend Yield
- ETON N/A
- UONEK N/A
- EPS Growth
- ETON N/A
- UONEK N/A
- EPS
- ETON N/A
- UONEK N/A
- Revenue
- ETON $48,327,000.00
- UONEK $437,499,000.00
- Revenue This Year
- ETON $103.21
- UONEK N/A
- Revenue Next Year
- ETON $51.34
- UONEK N/A
- P/E Ratio
- ETON N/A
- UONEK N/A
- Revenue Growth
- ETON 40.88
- UONEK N/A
- 52 Week Low
- ETON $3.25
- UONEK $0.44
- 52 Week High
- ETON $21.48
- UONEK $1.57
- Technical
- Relative Strength Index (RSI)
- ETON 54.31
- UONEK 63.74
- Support Level
- ETON $13.78
- UONEK $0.56
- Resistance Level
- ETON $16.27
- UONEK $1.40
- Average True Range (ATR)
- ETON 0.83
- UONEK 0.15
- MACD
- ETON 0.32
- UONEK 0.01
- Stochastic Oscillator
- ETON 77.67
- UONEK 29.76
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.